Saturday 17 October 2026 Export USNA’s income statement to Excel — free account

USANA Health Sciences, Inc.

USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.

15.54 0.16 +1.04%

Follow USNA

Alert me

Market cap: $284.2M
P/E: 0.0×
Fwd P/E: 14.0×
Dividend yield: —
F-score: 7/9
Altman Z: 3.59
Beneish M: n/a
Dividend safety: 70/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.96

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	2	2	—	1	2	—	4	4	—	—	—	—

Insider Ownership 40.93%

Capital & Financial Ratios $m

Market Cap 284.17

Revenue 913.36

Net Income (29.25)

Free Cash Flow 19.90

Net Debt (168.56)

Current Ratio 2.66

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E 14.00

P/S ratio 0.31

P/B ratio 0.55

Past 5Y EPS Growth (37.03%)

This Y EPS Growth (60.62%)

Next Y EPS Growth 132.89%

Next Y revenue growth (1.76%)

Next 5Y EPS Growth 2.26%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 1.92%

10-year low 10-year high

P/B against its own 10 years 1.92%

10-year low 10-year high

EV/Sales against its own 10 years 1.92%

10-year low 10-year high

EV/FCF against its own 10 years 11.57%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	330	182	158	169
Receivables	—	—	—	3
Inventory	61	70	103	86
Other	—	—	—	—
	418	279	288	281

	2023	2024	2025	Q'26
Payables	10	12	17	15
ST’ Debt	—	—	—	—
Other	108	105	97	90
	119	140	129	106

Compound Annual Growth %

	10y	5y	3y
Sales	0.07%	(4.00%)	(2.51%)
Cash Flow	(14.84%)	(32.58%)	(40.08%)
Earnings	(19.54%)	(38.73%)	(46.27%)
Book Value	6.62%	3.84%	7.06%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	250	223	—	—	—
’25	250	236	214	226	925
’24	228	213	200	214	855
’23	248	238	213	221	921
’22	273	264	233	228	999
’21	308	337	274	267	1,186
’20	267	259	299	311	1,135

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	10	23	—	—	—
’25	15	12	(2)	(3)	22
’24	18	8	30	6	61
’23	13	10	22	26	71
’22	20	15	29	40	104
’21	20	39	37	25	121
’20	31	33	49	48	160

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	7	20	—	—	—
’25	13	7	(5)	(2)	12
’24	14	5	27	4	51
’23	11	6	21	19	56
’22	18	13	26	37	94
’21	18	38	31	22	108
’20	24	29	46	46	145

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.41	(1.16)	—	—	—
’25	0.49	0.52	(0.36)	(0.10)	0.58
’24	0.86	0.54	0.56	0.23	2.19
’23	0.95	0.89	0.59	0.87	3.30
’22	1.15	1.00	0.78	0.66	3.59
’21	1.45	1.87	1.36	1.03	5.73
’20	1.23	1.32	1.44	1.87	5.86

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	46.00	52.55	69.55	58.30	43.01	77.06	48.61	44.01	31.44	18.48	Analyst estimates 2026–2028 Powerpack
	High	75.00	76.15	137.95	119.37	92.26	107.85	103.26	69.60	54.81	38.32
People
People	Employees	1,788	1,810	1,911	1,909	1,943	1,978	1,900	1,800	1,700	1,570
	Revenue/emp, $m	0.56	0.58	0.62	0.56	0.58	0.60	0.53	0.51	0.50	0.59
Income, $m
Income, $m	Revenue	1,006	1,047	1,189	1,061	1,135	1,186	999	921	855	925
	Gross margin, %	82.09	82.87	83.12	82.33	81.57	81.63	80.58	80.82	81.13	78.29
	EBT	139	135	192	150	178	171	109	102	76	42
	EBT margin, %	13.77	12.86	16.10	14.19	15.68	14.38	10.88	11.12	8.94	4.49
	Net income	100	63	126	101	125	117	69	64	42	11
	Depreciation	13	16	17	23	23	22	21	20	22	40
Per share, $
Per share, $	Revenue	41.60	43.01	49.34	46.85	53.63	58.89	51.86	47.84	44.73	49.92
	Earnings	3.99	2.53	5.12	4.41	5.86	5.73	3.59	3.30	2.19	0.58
	Cash flow	5.66	5.08	6.31	5.60	7.58	6.02	5.40	3.67	3.19	1.21
	Capex	(1.35)	(0.54)	(0.46)	(0.73)	(0.71)	(0.63)	(0.54)	(0.75)	(0.52)	(0.54)
	Free cash flow	4.31	4.54	5.85	4.87	6.87	5.38	4.86	2.92	2.67	0.67
	Book value	13.45	14.92	16.23	15.53	20.88	19.61	22.57	25.83	27.85	28.76
	Shares, m	24	24	24	23	21	20	19	19	19	19
Valuation, ×
Valuation, ×	P/E	16.13	29.74	23.04	17.77	13.16	17.72	15.17	16.50	16.31	35.69
	P/S	1.50	1.74	2.39	1.68	1.44	1.72	1.05	1.14	0.80	0.39
	P/B	4.62	5.02	7.26	5.06	3.69	5.16	2.41	2.11	1.29	0.68
	EV/Sales	1.39	1.57	2.21	1.52	1.22	1.57	0.83	0.85	0.67	0.29
	EV/FCF	13.38	14.87	18.62	14.61	9.53	17.19	8.84	13.96	11.18	21.84
Cash, $m
Cash, $m	Operating cash flow	137	124	152	127	160	121	104	71	61	22
	Capex	(33)	(13)	(11)	(17)	(15)	(13)	(10)	(14)	(10)	(10)
	Free cash flow	104	111	141	110	145	108	94	56	51	12
Balance, $m
Balance, $m	Working capital	139	199	244	193	257	204	241	299	140	160
	Total debt	—	—	—	26	21	17	14	—	—	—
	Net debt	(176)	(247)	(278)	(235)	(312)	(240)	(288)	(330)	(182)	(158)
	Shareholders’ equity	325	363	391	352	442	395	434	497	532	533
Returns, %
Returns, %	ROA	22.38	12.63	23.51	18.77	21.53	19.12	11.81	10.38	6.09	1.44
	ROIC	57.95	71.34	103.92	78.17	85.03	68.50	46.05	34.88	11.83	6.24
	ROE	33.01	18.17	33.47	27.06	31.43	27.85	16.72	13.69	8.17	2.02

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ENHA Enhanced Group Inc.	$498.5M	17.1×	—	—	n/m	−483.42% (below 0%: shrinking)	100.00%	(349.85%)	Compare
OTLY Oatly Group AB Sponsored ADR	$356.4M	— (loss-making)	— (loss-making)	+15.23% (above 0%: growing)	n/m	+89.27% (above 0%: growing)	33.89%	(7.21%)	Compare
PRE Prenetics Global Limited	$347.3M	— (loss-making)	— (loss-making)	+288.57% (above 0%: growing)	n/m	−297.16% (below 0%: shrinking)	64.97%	(45.13%)	Compare
LWAY Lifeway Foods, Inc.	$335.5M	30.7×	23.4×	+24.10% (above 0%: growing)	−96.43% (below 0%: shrinking)	−598.84% (below 0%: shrinking)	19.47%	0.90%	Compare
USNA USANA Health Sciences, Inc.	$284.2M	— (loss-making)	14.0×	−5.33% (below 0%: shrinking)	n/m	+180.61% (above 0%: growing)	78.35%	(8.96%)
BRCC BRC Inc.	$263.3M	— (loss-making)	43.0×	+12.85% (above 0%: growing)	n/m	+226.39% (above 0%: growing)	34.09%	1.03%	Compare
NATR Nature's Sunshine Products, Inc.	$222.4M	12.4×	16.4×	+1.95% (above 0%: growing)	−31.03% (below 0%: shrinking)	−164.92% (below 0%: shrinking)	73.66%	4.69%	Compare
BGS B&G Foods, Inc.	$196.7M	— (loss-making)	— (loss-making)	−9.70% (below 0%: shrinking)	n/m	+19.28% (above 0%: growing)	20.78%	9.02%	Compare
BYND Beyond Meat, Inc.	$131.2M	— (loss-making)	— (loss-making)	−8.17% (below 0%: shrinking)	n/m	+44.64% (above 0%: growing)	8.53%	(44.76%)	Compare
Median of peers	$299.4M	17.1×	23.4×	+12.85%	—	−72.82%	33.99%	(3.15%)

All 71 Packaged Foods stocks →

USANA Health Sciences, Inc. (USNA) key facts

Concern: Net income was $11.5 million, or $0.58 per share (basic), a net margin of 1.16%.
Strength: USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024.
USANA Health Sciences, Inc. (USNA) is a Packaged Foods company in the Consumer Defensive sector, listed on the New York Stock Exchange.
As of October 16, 2026, USNA traded at $15.54, a market capitalization of $284.2 million.
Return on equity was 2.02% and debt-to-equity 0.00.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.59 (safe zone) for fiscal 2025.